Adaptive Tissue Ablation Systems for Personalized Electroporation
Legal Citation
Summary of the Inventive Concept
The present inventive concept discloses advanced tissue ablation systems that integrate real-time monitoring, adaptive frequency modulation, and personalized pulse sequences to achieve optimized electroporation outcomes.
Background and Problem Solved
The original patent disclosed methods and systems for tissue ablation using pulse shape designs, which have limitations in terms of fixed pulse sequences and lack of real-time monitoring. The present inventive concept addresses these limitations by introducing adaptive frequency modulation, 3D mapping, and real-time monitoring to ensure precise and personalized tissue ablation.
Detailed Description of the Inventive Concept
The new inventive concept comprises a system for tissue ablation that includes a pulse generator with adaptive frequency modulation, a 3D mapping module, and a sensor array for real-time monitoring of tissue impedance, temperature, and electrical conductivity. The system generates a customized pulse sequence based on the 3D map and adjusts it in real-time according to the detected changes in tissue properties. This allows for optimized electroporation outcomes, reduced treatment time, and minimized side effects.
Novelty and Inventive Step
The present inventive concept introduces a paradigm shift in tissue ablation by integrating real-time monitoring, adaptive frequency modulation, and personalized pulse sequences, which is a significant departure from the fixed pulse sequences of the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of machine learning algorithms to predict optimal pulse sequences, the integration of multiple sensing modalities, or the development of implantable devices for chronic tissue ablation.
Potential Commercial Applications and Market
The present inventive concept has significant commercial potential in the medical device industry, particularly in the fields of cancer treatment, cardiac ablation, and cosmetic dermatology. The market for tissue ablation devices is expected to grow significantly in the next decade, driven by the increasing demand for minimally invasive procedures and personalized medicine.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B18/1206 |
| A | A61 | A61B18/1402 |
| A | A61 | A61N1/205 |
| A | A61 | A61N1/327 |
| A | A61 | A61B5/14539 |
| A | A61 | A61B2018/00577 |
| A | A61 | A61B2018/00613 |
| A | A61 | A61B2018/00827 |
| A | A61 | A61B2018/00994 |
| A | A61 | A61B2018/1266 |
| A | A61 | A61B2018/1472 |
Original Patent Information
| Patent Number | US 11,857,244 |
|---|---|
| Title | Methods, systems, and apparatuses for tissue ablation using pulse shape designs |
| Assignee(s) | RM2 TECHNOLOGY LLC, Inter Science GmbH |